Genpact Limited (G) Expected to Post Quarterly Sales of $682.11 Million

Brokerages predict that Genpact Limited (NYSE:G) will announce $682.11 million in sales for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for Genpact’s earnings. The highest sales estimate is $691.04 million and the lowest is $674.80 million. Genpact reported sales of $623.00 million during the same quarter last year, which indicates a positive year-over-year growth rate of 9.5%. The firm is scheduled to report its next earnings report after the market closes on Thursday, May 3rd.

On average, analysts expect that Genpact will report full year sales of $682.11 million for the current fiscal year, with estimates ranging from $2.94 billion to $2.99 billion. For the next year, analysts anticipate that the business will post sales of $3.19 billion per share, with estimates ranging from $3.13 billion to $3.23 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Genpact.

How to Become a New Pot Stock Millionaire

Genpact (NYSE:G) last released its quarterly earnings data on Monday, February 12th. The business services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.02. Genpact had a net margin of 9.61% and a return on equity of 22.75%. The company had revenue of $734.41 million during the quarter, compared to the consensus estimate of $723.55 million. During the same quarter in the prior year, the firm posted $0.43 earnings per share. Genpact’s revenue for the quarter was up 7.7% on a year-over-year basis.

Several research firms have issued reports on G. Citigroup decreased their price objective on shares of Genpact from $39.00 to $37.50 and set a “buy” rating for the company in a research note on Tuesday, February 13th. BMO Capital Markets increased their target price on shares of Genpact to $35.00 and gave the stock a “market perform” rating in a research note on Tuesday, February 13th. JPMorgan Chase decreased their target price on shares of Genpact from $38.00 to $37.00 and set a “neutral” rating for the company in a research note on Wednesday, February 14th. Cantor Fitzgerald reissued a “buy” rating and set a $36.00 price target on shares of Genpact in a report on Tuesday, February 13th. Finally, Zacks Investment Research cut shares of Genpact from a “hold” rating to a “sell” rating in a report on Thursday, February 15th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $34.65.

NYSE G traded down $0.04 during trading hours on Tuesday, hitting $31.86. The company had a trading volume of 88,808 shares, compared to its average volume of 784,313. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.71 and a quick ratio of 1.71. Genpact has a 1-year low of $23.51 and a 1-year high of $34.79. The company has a market capitalization of $6,125.55, a PE ratio of 21.41, a P/E/G ratio of 2.04 and a beta of 0.60.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 21st. Stockholders of record on Friday, March 9th were paid a dividend of $0.075 per share. This represents a $0.30 dividend on an annualized basis and a dividend yield of 0.94%. This is a boost from Genpact’s previous quarterly dividend of $0.06. The ex-dividend date was Thursday, March 8th. Genpact’s dividend payout ratio (DPR) is 20.13%.

In related news, insider Arvinder Singh sold 22,690 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $33.95, for a total transaction of $770,325.50. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director James C. Madden sold 4,270 shares of the firm’s stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $30.92, for a total transaction of $132,028.40. The disclosure for this sale can be found here. Company insiders own 1.41% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Robeco Institutional Asset Management B.V. bought a new stake in shares of Genpact in the fourth quarter valued at about $38,064,000. Westwood Holdings Group Inc. acquired a new position in Genpact in the fourth quarter valued at about $24,974,000. BlackRock Inc. raised its stake in Genpact by 6.6% in the fourth quarter. BlackRock Inc. now owns 12,772,040 shares of the business services provider’s stock valued at $405,384,000 after purchasing an additional 785,600 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in Genpact by 67.6% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,492,619 shares of the business services provider’s stock valued at $47,376,000 after purchasing an additional 602,090 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in Genpact by 32.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 2,408,046 shares of the business services provider’s stock valued at $76,431,000 after purchasing an additional 587,149 shares in the last quarter. Hedge funds and other institutional investors own 91.01% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Genpact Limited (G) Expected to Post Quarterly Sales of $682.11 Million” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/13/genpact-limited-g-expected-to-post-quarterly-sales-of-682-11-million.html.

About Genpact

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Get a free copy of the Zacks research report on Genpact (G)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply